1007 Prodigiosin Increases Ubiquitin-ligases Gene Expression in Human Melanoma Cell Line SK-MEL-5
C.M. Garcia(Washington University in St. Louis), Sı́lvia Busquets, Josep M. Argilés(Universitat de Barcelona), Marion de Toledo(Universidade do Porto), Ricardo Pérez‐Tomás(Bellvitge University Hospital), Francisco J. López‐Soriano(Universitat de Barcelona), Margarita Espona‐Fiedler(Umeå University), Frank J. Penna, M.P. Aylwin, Vanessa Soto‐Cerrato(Institut d'Investigació Biomédica de Bellvitge)
Cited by 0
Related Papers
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma
|Modern Pathology|2014|174
Synthetic Prodiginine Obatoclax (GX15‐070) and Related Analogues: Anion Binding, Transmembrane Transport, and Cytotoxicity Properties
|Chemistry - A European Journal|2011|116
<scp>FLIP</scp> as a therapeutic target in cancer
|FEBS Journal|2018|86
Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life
|PLoS ONE|2015|76
Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax
|Biochemical Pharmacology|2011|74